NOTIZIE E RICERCA
Un unico blog, con notizie nella lingua originale delle fonti. Gli articoli storici non rappresentano necessariamente le indicazioni cliniche attuali.
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)—ipilimumab and tremelimumab—have been investigated in metastatic melanoma and other cancers and
Read article ↗Un articolo pubblicato nel Journal of Clinical Oncology evidenzia la gestione degli effetti collaterali della terapia con ipilimumab e tremelimumab nel melanoma metastatico: “Monoclonal
Read article ↗A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to
Read article ↗A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to
Read article ↗Although invasive cutaneous melanoma is primarily a malignancy of adulthood, the heightened relative risk of second primary melanomas in the pediatric population calls for
Read article ↗ADVERTISEMENT
ADVERTISEMENT